Scout Investments’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-125,571
| Closed | -$3.59M | – | 207 |
|
|
2024
Q2 | $3.59M | Sell |
125,571
-12,010
| -9% | -$344K | 0.1% | 190 |
|
|
2024
Q1 | $4.01M | Sell |
137,581
-8,764
| -6% | -$255K | 0.1% | 189 |
|
|
2023
Q4 | $4.94M | Sell |
146,345
-2,299
| -2% | -$77.6K | 0.12% | 189 |
|
|
2023
Q3 | $4.44M | Sell |
148,644
-4,321
| -3% | -$129K | 0.1% | 193 |
|
|
2023
Q2 | $5.54M | Sell |
152,965
-4,548
| -3% | -$165K | 0.11% | 186 |
|
|
2023
Q1 | $6.43M | Buy |
157,513
+8,985
| +6% | +$367K | 0.13% | 172 |
|
|
2022
Q4 | $5.73M | Sell |
148,528
-2,469
| -2% | -$95.3K | 0.12% | 179 |
|
|
2022
Q3 | $8.03M | Buy |
150,997
+6,021
| +4% | +$320K | 0.17% | 154 |
|
|
2022
Q2 | $8.45M | Buy |
144,976
+14,364
| +11% | +$837K | 0.17% | 153 |
|
|
2022
Q1 | $9.97M | Sell |
130,612
-173
| -0.1% | -$13.2K | 0.16% | 152 |
|
|
2021
Q4 | $7.87M | Sell |
130,785
-2,951
| -2% | -$178K | 0.11% | 211 |
|
|
2021
Q3 | $7.49M | Buy |
133,736
+2,514
| +2% | +$141K | 0.11% | 225 |
|
|
2021
Q2 | $7.96M | Buy |
131,222
+16,488
| +14% | +$1M | 0.12% | 223 |
|
|
2021
Q1 | $8.04M | Buy |
+114,734
| New | +$8.04M | 0.12% | 236 |
|